Invention Publication
- Patent Title: Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS
-
Application No.: US17806187Application Date: 2022-06-09
-
Publication No.: US20230183350A1Publication Date: 2023-06-15
- Inventor: Michal Eisenbach-Schwartz , Kuti Baruch , Neta Rosenzweig
- Applicant: Yeda Research and Development Co. Ltd.
- Applicant Address: IL Rehovot
- Assignee: Yeda Research and Development Co. Ltd.
- Current Assignee: Yeda Research and Development Co. Ltd.
- Current Assignee Address: IL Rehovot
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K31/4155 ; A61K31/7068 ; A61K31/404 ; A61K33/36 ; A61K45/06 ; A61P25/16 ; A61P37/06 ; A61P25/28 ; A61P27/02
Abstract:
The present specification discloses a pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the CNS. The pharmaceutical composition is administered by a dosage regimen comprising at least one course of therapy, each course of therapy comprising in sequence a treatment session followed by an interval session of non-treatment.
Information query
